{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T16:38:20Z","timestamp":1777653500832,"version":"3.51.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T00:00:00Z","timestamp":1558483200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T00:00:00Z","timestamp":1558483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NIH R01CA176001"],"award-info":[{"award-number":["NIH R01CA176001"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["NIH P30EY06360"],"award-info":[{"award-number":["NIH P30EY06360"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Researh to Prevent Blindness"},{"name":"Gerwin Fellowship"},{"name":"930 Friends"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12885-019-5712-3","type":"journal-article","created":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T13:03:36Z","timestamp":1558530216000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Natural killer cells and pigment epithelial-derived factor control the infiltrative and nodular growth of hepatic metastases in an Orthotopic murine model of ocular melanoma"],"prefix":"10.1186","volume":"19","author":[{"given":"Nyasia M.","family":"Jones","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa M.","family":"Morales-Tirado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans E.","family":"Grossniklaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,22]]},"reference":[{"issue":"6","key":"5712_CR1","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1097\/00008390-199912000-00006","volume":"9","author":"E Woll","year":"1999","unstructured":"Woll E, Bedikian A, Legha SS. Uveal melanoma: natural history and treatment options for metastatic disease. Melanoma Res. 1999;9(6):575\u201381.","journal-title":"Melanoma Res"},{"issue":"2","key":"5712_CR2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.sjopt.2012.02.010","volume":"26","author":"C Miyamoto","year":"2012","unstructured":"Miyamoto C, Balazsi M, Bakalian S, Fernandes BF, Burnier MN Jr. Uveal melanoma: ocular and systemic disease. Saudi J Ophthalmol. 2012;26(2):145\u20139.","journal-title":"Saudi J Ophthalmol"},{"issue":"2","key":"5712_CR3","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/eye.2012.237","volume":"27","author":"RC Eagle Jr","year":"2013","unstructured":"Eagle RC Jr. The pathology of ocular cancer. Eye. 2013;27(2):128\u201336.","journal-title":"Eye"},{"issue":"12","key":"5712_CR4","doi-asserted-by":"publisher","first-page":"5522","DOI":"10.1167\/iovs.09-3804","volume":"50","author":"H Li","year":"2009","unstructured":"Li H, Yang W, Chen PW, Alizadeh H, Niederkorn JY. Inhibition of chemokine receptor expression on uveal melanomas by CXCR4 siRNA and its effect on uveal melanoma liver metastases. Invest Ophthalmol Vis Sci. 2009;50(12):5522\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"5712_CR5","doi-asserted-by":"publisher","first-page":"4175","DOI":"10.1007\/s13277-015-4259-4","volume":"37","author":"J Bi","year":"2016","unstructured":"Bi J, Li P, Li C, He J, Wang Y, Zhang H, Fan X, Jia R, Ge S. The SDF-1\/CXCR4 chemokine axis in uveal melanoma cell proliferation and migration. Tumour Biol. 2016;37(3):4175\u201382.","journal-title":"Tumour Biol"},{"issue":"2","key":"5712_CR6","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1167\/iovs.07-1035","volume":"49","author":"H Li","year":"2008","unstructured":"Li H, Alizadeh H, Niederkorn JY. Differential expression of chemokine receptors on uveal melanoma cells and their metastases. Invest Ophthalmol Vis Sci. 2008;49(2):636\u201343.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"5712_CR7","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1167\/iovs.07-0975","volume":"49","author":"M Ye","year":"2008","unstructured":"Ye M, Hu D, Tu L, Zhou X, Lu F, Wen B, Wu W, Lin Y, Zhou Z, Qu J. Involvement of PI3K\/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells. Invest Ophthalmol Vis Sci. 2008;49(2):497\u2013504.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"5712_CR8","first-page":"855","volume":"152","author":"MJ Hendrix","year":"1998","unstructured":"Hendrix MJ, Seftor EA, Seftor RE, Kirschmann DA, Gardner LM, Boldt HC, Meyer M, Pe'er J, Folberg R. Regulation of uveal melanoma interconverted phenotype by hepatocyte growth factor\/scatter factor (HGF\/SF). Am J Pathol. 1998;152(4):855\u201363.","journal-title":"Am J Pathol"},{"key":"5712_CR9","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.humpath.2016.07.012","volume":"57","author":"HE Grossniklaus","year":"2016","unstructured":"Grossniklaus HE, Zhang Q, You S, McCarthy C, Heegaard S, Coupland SE. Metastatic ocular melanoma to the liver exhibits infiltrative and nodular growth patterns. Hum Pathol. 2016;57:165\u201375.","journal-title":"Hum Pathol"},{"issue":"7","key":"5712_CR10","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1158\/0008-5472.CAN-12-3931","volume":"73","author":"GG Van den Eynden","year":"2013","unstructured":"Van den Eynden GG, Majeed AW, Illemann M, Vermeulen PB, Bird NC, Hoyer-Hansen G, Eefsen RL, Reynolds AR, Brodt P. The multifaceted role of the microenvironment in liver metastasis: biology and clinical implications. Cancer Res. 2013;73(7):2031\u201343.","journal-title":"Cancer Res"},{"issue":"6","key":"5712_CR11","first-page":"1277","volume":"38","author":"RS Apte","year":"1997","unstructured":"Apte RS, Mayhew E, Niederkorn JY. Local inhibition of natural killer cell activity promotes the progressive growth of intraocular tumors. Invest Ophthalmol Vis Sci. 1997;38(6):1277\u201382.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"5712_CR12","doi-asserted-by":"publisher","first-page":"710","DOI":"10.4049\/jimmunol.165.2.710","volume":"165","author":"AC Repp","year":"2000","unstructured":"Repp AC, Mayhew ES, Apte S, Niederkorn JY. Human uveal melanoma cells produce macrophage migration-inhibitory factor to prevent lysis by NK cells. J Immunol. 2000;165(2):710\u20135.","journal-title":"J Immunol"},{"issue":"3","key":"5712_CR13","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.18632\/oncotarget.6500","volume":"7","author":"H Yang","year":"2016","unstructured":"Yang H, Brackett CM, Morales-Tirado VM, Li Z, Zhang Q, Wilson MW, Benjamin C, Harris W, Waller EK, Gudkov AV, et al. The toll-like receptor 5 agonist entolimod suppresses hepatic metastases in a murine model of ocular melanoma via an NK cell-dependent mechanism. Oncotarget. 2016;7(3):2936\u201350.","journal-title":"Oncotarget"},{"key":"5712_CR14","first-page":"511","volume":"12","author":"H Yang","year":"2006","unstructured":"Yang H, Xu Z, Iuvone PM, Grossniklaus HE. Angiostatin decreases cell migration and vascular endothelium growth factor (VEGF) to pigment epithelium derived factor (PEDF) RNA ratio in vitro and in a murine ocular melanoma model. Mol Vis. 2006;12:511\u20137.","journal-title":"Mol Vis"},{"issue":"1","key":"5712_CR15","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1167\/iovs.09-4138","volume":"51","author":"H Yang","year":"2010","unstructured":"Yang H, Grossniklaus HE. Constitutive overexpression of pigment epithelium-derived factor inhibition of ocular melanoma growth and metastasis. Invest Ophthalmol Vis Sci. 2010;51(1):28\u201334.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"5712_CR16","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/nm870","volume":"9","author":"JA Doll","year":"2003","unstructured":"Doll JA, Stellmach VM, Bouck NP, Bergh AR, Lee C, Abramson LP, Cornwell ML, Pins MR, Borensztajn J, Crawford SE. Pigment epithelium-derived factor regulates the vasculature and mass of the prostate and pancreas. Nat Med. 2003;9(6):774\u201380.","journal-title":"Nat Med"},{"issue":"7","key":"5712_CR17","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1167\/iovs.03-1331","volume":"45","author":"H Yang","year":"2004","unstructured":"Yang H, Dithmar S, Grossniklaus HE. Interferon alpha 2b decreases hepatic micrometastasis in a murine model of ocular melanoma by activation of intrinsic hepatic natural killer cells. Invest Ophthalmol Vis Sci. 2004;45(7):2056\u201364.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"5712_CR18","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1076\/ceyr.18.2.125.5380","volume":"18","author":"CE Diaz","year":"1999","unstructured":"Diaz CE, Rusciano D, Dithmar S, Grossniklaus HE. B16LS9 melanoma cells spread to the liver from the murine ocular posterior compartment (PC). Curr Eye Res. 1999;18(2):125\u20139.","journal-title":"Curr Eye Res"},{"issue":"8","key":"5712_CR19","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s10585-013-9596-3","volume":"30","author":"JM Lattier","year":"2013","unstructured":"Lattier JM, Yang H, Crawford S, Grossniklaus HE. Host pigment epithelium-derived factor (PEDF) prevents progression of liver metastasis in a mouse model of uveal melanoma. Clin Exp Metastasis. 2013;30(8):969\u201376.","journal-title":"Clin Exp Metastasis"},{"key":"5712_CR20","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13098-015-0068-6","volume":"7","author":"BT Gao","year":"2015","unstructured":"Gao BT, Lee RP, Jiang Y, Steinle JJ, Morales-Tirado VM. Pioglitazone alters monocyte populations and stimulates recent thymic emigrants in the BBDZR\/Wor type 2 diabetes rat model. Diabetol Metab Syndr. 2015;7:72.","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"5712_CR21","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1186\/s12885-017-3418-y","volume":"17","author":"AH Webb","year":"2017","unstructured":"Webb AH, Gao BT, Goldsmith ZK, Irvine AS, Saleh N, Lee RP, Lendermon JB, Bheemreddy R, Zhang Q, Brennan RC, et al. Inhibition of MMP-2 and MMP-9 decreases cellular migration, and angiogenesis in in vitro models of retinoblastoma. BMC Cancer. 2017;17(1):434.","journal-title":"BMC Cancer"},{"issue":"5","key":"5712_CR22","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.4049\/jimmunol.153.5.2021","volume":"153","author":"HV Nielsen","year":"1994","unstructured":"Nielsen HV, Christensen JP, Andersson EC, Marker O, Thomsen AR. Expression of type 3 complement receptor on activated CD8+ T cells facilitates homing to inflammatory sites. J Immunol. 1994;153(5):2021\u20138.","journal-title":"J Immunol"},{"issue":"4","key":"5712_CR23","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/eji.1830090410","volume":"9","author":"T Springer","year":"1979","unstructured":"Springer T, Galfre G, Secher DS, Milstein C. Mac-1: a macrophage differentiation antigen identified by monoclonal antibody. Eur J Immunol. 1979;9(4):301\u20136.","journal-title":"Eur J Immunol"},{"issue":"4","key":"5712_CR24","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1172\/JCI109923","volume":"66","author":"HD Kay","year":"1980","unstructured":"Kay HD, Horwitz DA. Evidence by reactivity with hybridoma antibodies for a probable myeloid origin of peripheral blood cells active in natural cytotoxicity and antibody-dependent cell-mediated cytotoxicity. J Clin Invest. 1980;66(4):847\u201351.","journal-title":"J Clin Invest"},{"issue":"5789","key":"5712_CR25","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/288394a0","volume":"288","author":"JM Zarling","year":"1980","unstructured":"Zarling JM, Kung PC. Monoclonal antibodies which distinguish between human NK cells and cytotoxic T lymphocytes. Nature. 1980;288(5789):394\u20136.","journal-title":"Nature"},{"key":"5712_CR26","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.exer.2012.11.012","volume":"107","author":"MC Herwig","year":"2013","unstructured":"Herwig MC, Bergstrom C, Wells JR, Holler T, Grossniklaus HE. M2\/M1 ratio of tumor associated macrophages and PPAR-gamma expression in uveal melanomas with class 1 and class 2 molecular profiles. Exp Eye Res. 2013;107:52\u20138.","journal-title":"Exp Eye Res"},{"issue":"4","key":"5712_CR27","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1586\/eop.11.45","volume":"6","author":"MC Herwig","year":"2011","unstructured":"Herwig MC, Grossniklaus HE. Role of macrophages in uveal melanoma. Expert Rev Ophthalmol. 2011;6(4):405\u20137.","journal-title":"Expert Rev Ophthalmol"},{"issue":"2","key":"5712_CR28","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.preteyeres.2010.11.004","volume":"30","author":"MJ Jager","year":"2011","unstructured":"Jager MJ, Ly LV, El Filali M, Madigan MC. Macrophages in uveal melanoma and in experimental ocular tumor models: friends or foes? Prog Retin Eye Res. 2011;30(2):129\u201346.","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"5712_CR29","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1167\/iovs.10-5979","volume":"52","author":"IH Bronkhorst","year":"2011","unstructured":"Bronkhorst IH, Ly LV, Jordanova ES, Vrolijk J, Versluis M, Luyten GP, Jager MJ. Detection of M2-macrophages in uveal melanoma and relation with survival. Invest Ophthalmol Vis Sci. 2011;52(2):643\u201350.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"5712_CR30","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.4049\/jimmunol.0903479","volume":"185","author":"LV Ly","year":"2010","unstructured":"Ly LV, Baghat A, Versluis M, Jordanova ES, Luyten GP, van Rooijen N, van Hall T, van der Velden PA, Jager MJ. In aged mice, outgrowth of intraocular melanoma depends on proangiogenic M2-type macrophages. J Immunol. 2010;185(6):3481\u20138.","journal-title":"J Immunol"},{"issue":"7","key":"5712_CR31","first-page":"1414","volume":"42","author":"T Makitie","year":"2001","unstructured":"Makitie T, Summanen P, Tarkkanen A, Kivela T. Tumor-infiltrating macrophages (CD68(+) cells) and prognosis in malignant uveal melanoma. Invest Ophthalmol Vis Sci. 2001;42(7):1414\u201321.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"5712_CR32","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/(SICI)1097-0215(20000115)85:2%3C182::AID-IJC6%3E3.0.CO;2-M","volume":"85","author":"H Torisu","year":"2000","unstructured":"Torisu H, Ono M, Kiryu H, Furue M, Ohmoto Y, Nakayama J, Nishioka Y, Sone S, Kuwano M. Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: possible involvement of TNFalpha and IL-1alpha. Int J Cancer. 2000;85(2):182\u20138.","journal-title":"Int J Cancer"},{"issue":"6","key":"5712_CR33","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/S0002-9394(98)00040-3","volume":"125","author":"COMS","year":"1998","unstructured":"COMS. Histopathologic characteristics of uveal melanomas in eyes enucleated from the collaborative ocular melanoma study. COMS report no. 6. Am J Ophthalmol. 1998;125(6):745\u201366.","journal-title":"Am J Ophthalmol"},{"key":"5712_CR34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.12703\/P6-13","volume":"6","author":"FO Martinez","year":"2014","unstructured":"Martinez FO, Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000prime Rep. 2014;6:13.","journal-title":"F1000prime Rep"},{"key":"5712_CR35","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3389\/fimmu.2014.00514","volume":"5","author":"P Italiani","year":"2014","unstructured":"Italiani P, Boraschi D. From monocytes to M1\/M2 macrophages: phenotypical vs. functional differentiation. Front Immunol. 2014;5:514.","journal-title":"Front Immunol"},{"issue":"23","key":"5712_CR36","doi-asserted-by":"publisher","first-page":"12027","DOI":"10.18632\/oncotarget.2482","volume":"5","author":"M Tham","year":"2014","unstructured":"Tham M, Tan KW, Keeble J, Wang X, Hubert S, Barron L, Tan NS, Kato M, Prevost-Blondel A, Angeli V, et al. Melanoma-initiating cells exploit M2 macrophage TGFbeta and arginase pathway for survival and proliferation. Oncotarget. 2014;5(23):12027\u201342.","journal-title":"Oncotarget"},{"issue":"7","key":"5712_CR37","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s00262-017-1991-1","volume":"66","author":"G Gezgin","year":"2017","unstructured":"Gezgin G, Dogrusoz M, van Essen TH, Kroes WGM, Luyten GPM, van der Velden PA, Walter V, Verdijk RM, van Hall T, van der Burg SH, et al. Genetic evolution of uveal melanoma guides the development of an inflammatory microenvironment. Cancer Immunol Immunother. 2017;66(7):903\u201312.","journal-title":"Cancer Immunol Immunother"},{"issue":"10","key":"5712_CR38","doi-asserted-by":"publisher","first-page":"7337","DOI":"10.1074\/jbc.275.10.7337","volume":"275","author":"M Schuler","year":"2000","unstructured":"Schuler M, Bossy-Wetzel E, Goldstein JC, Fitzgerald P, Green DR. p53 induces apoptosis by caspase activation through mitochondrial cytochrome c release. J Biol Chem. 2000;275(10):7337\u201342.","journal-title":"J Biol Chem"},{"issue":"25","key":"5712_CR39","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.1016\/j.lfs.2005.05.048","volume":"77","author":"K Takenaka","year":"2005","unstructured":"Takenaka K, Yamagishi S, Jinnouchi Y, Nakamura K, Matsui T, Imaizumi T. Pigment epithelium-derived factor (PEDF)-induced apoptosis and inhibition of vascular endothelial growth factor (VEGF) expression in MG63 human osteosarcoma cells. Life Sci. 2005;77(25):3231\u201341.","journal-title":"Life Sci"},{"issue":"19","key":"5712_CR40","doi-asserted-by":"publisher","first-page":"7503","DOI":"10.1158\/0008-5472.CAN-09-2152","volume":"69","author":"S Nagaraj","year":"2009","unstructured":"Nagaraj S, Collazo M, Corzo CA, Youn JI, Ortiz M, Quiceno D, Gabrilovich DI. Regulatory myeloid suppressor cells in health and disease. Cancer Res. 2009;69(19):7503\u20136.","journal-title":"Cancer Res"},{"issue":"3","key":"5712_CR41","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nri2506","volume":"9","author":"DI Gabrilovich","year":"2009","unstructured":"Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol. 2009;9(3):162\u201374.","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"5712_CR42","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1158\/0008-5472.CAN-10-2583","volume":"71","author":"AD Gregory","year":"2011","unstructured":"Gregory AD, Houghton AM. Tumor-associated neutrophils: new targets for cancer therapy. Cancer Res. 2011;71(7):2411\u20136.","journal-title":"Cancer Res"},{"issue":"2","key":"5712_CR43","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1189\/jlb.0310162","volume":"89","author":"S Brandau","year":"2011","unstructured":"Brandau S, Trellakis S, Bruderek K, Schmaltz D, Steller G, Elian M, Suttmann H, Schenck M, Welling J, Zabel P, et al. Myeloid-derived suppressor cells in the peripheral blood of cancer patients contain a subset of immature neutrophils with impaired migratory properties. J Leukoc Biol. 2011;89(2):311\u20137.","journal-title":"J Leukoc Biol"},{"issue":"12","key":"5712_CR44","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1200\/JCO.2006.09.0274","volume":"25","author":"H Schmidt","year":"2007","unstructured":"Schmidt H, Suciu S, Punt CJ, Gore M, Kruit W, Patel P, Lienard D, von der Maase H, Eggermont AM, Keilholz U, et al. Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American joint committee on Cancer stage IV melanoma: results of the EORTC 18951 biochemotherapy trial. J Clin Oncol. 2007;25(12):1562\u20139.","journal-title":"J Clin Oncol"},{"issue":"1","key":"5712_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0053131","volume":"8","author":"K Hayata","year":"2013","unstructured":"Hayata K, Iwahashi M, Ojima T, Katsuda M, Iida T, Nakamori M, Ueda K, Nakamura M, Miyazawa M, Tsuji T, et al. Inhibition of IL-17A in tumor microenvironment augments cytotoxicity of tumor-infiltrating lymphocytes in tumor-bearing mice. PLoS One. 2013;8(1):e53131.","journal-title":"PLoS One"},{"issue":"2","key":"5712_CR46","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1182\/blood.V97.2.339","volume":"97","author":"E Di Carlo","year":"2001","unstructured":"Di Carlo E, Forni G, Lollini P, Colombo MP, Modesti A, Musiani P. The intriguing role of polymorphonuclear neutrophils in antitumor reactions. Blood. 2001;97(2):339\u201345.","journal-title":"Blood"},{"issue":"11","key":"5712_CR47","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1007\/s00262-013-1476-9","volume":"62","author":"I Mishalian","year":"2013","unstructured":"Mishalian I, Bayuh R, Levy L, Zolotarov L, Michaeli J, Fridlender ZG. Tumor-associated neutrophils (TAN) develop pro-tumorigenic properties during tumor progression. Cancer Immunol Immunother. 2013;62(11):1745\u201356.","journal-title":"Cancer Immunol Immunother"},{"issue":"2","key":"5712_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0031524","volume":"7","author":"ZG Fridlender","year":"2012","unstructured":"Fridlender ZG, Sun J, Mishalian I, Singhal S, Cheng G, Kapoor V, Horng W, Fridlender G, Bayuh R, Worthen GS, et al. Transcriptomic analysis comparing tumor-associated neutrophils with granulocytic myeloid-derived suppressor cells and normal neutrophils. PLoS One. 2012;7(2):e31524.","journal-title":"PLoS One"},{"issue":"3","key":"5712_CR49","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.critrevonc.2011.06.004","volume":"82","author":"H Piccard","year":"2012","unstructured":"Piccard H, Muschel RJ, Opdenakker G. On the dual roles and polarized phenotypes of neutrophils in tumor development and progression. Crit Rev Oncol Hematol. 2012;82(3):296\u2013309.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"5","key":"5712_CR50","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1002\/ijc.29480","volume":"137","author":"L Sadegh","year":"2015","unstructured":"Sadegh L, Chen PW, Brown JR, Han Z, Niederkorn JY. NKT cells act through third party bone marrow-derived cells to suppress NK cell activity in the liver and exacerbate hepatic melanoma metastases. Int J Cancer. 2015;137(5):1085\u201394.","journal-title":"Int J Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5712-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-5712-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5712-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T20:22:44Z","timestamp":1694895764000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-5712-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,22]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["5712"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-5712-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,22]]},"assertion":[{"value":"14 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"HY is an Associate Professor at the Research Section of the Department of Ophthalmology at Emory University, who focuses on anti-angiogenic and immune modulatory therapies against metastatic uveal melanoma. VMT is an Assistant Professor at the Departments of Ophthalmology and Microbiology, Immunology and Biochemistry (MIB) at the University of Tennessee Health Science Center. She leads the Ocular Oncology and Immunology Translational Research Unit at UTHSC and has expertise in human tumor immunology, intraocular tumors and pre-clinical models of disease. HEG serves as the Interim Vice Chair at the Emory Eye Center, founding director of the Ocular Oncology and Pathology Service and Director of the L.F. Montgomery Laboratory at Emory. HEG is considered an international expert in diagnostic ophthalmic pathology, and ocular oncology with over 500 publications in peer reviewed journals, over 25 book chapters and edited 10 books.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 information"}},{"value":"This study was approved by the Emory University School of Medicine Institutional Animal Care and Utilization Committee (IACUC).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"484"}}